The Joint Senate and House Insurance and Commerce Committee is meeting December 16 to discuss Rule 128, which enforces existing law prohibiting below-cost reimbursement in the commercial market. Company testimony and support letters are crucial for the success of this meeting. Rule 128 is critical for fully enforcing Act 3 of 2018, helping to prevent unreasonable underpayments that threaten patient access and addressing excessive overpayments that drive up costs.
For more information, contact NACDS’ Mary Staples at 817-442-1155.